Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 1
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX - The LAPC-2 trial.
van 't Land FR, Latifi D, Moskie M, Homs MYV, Bosscha K, Bonsing BA, Mieog SD, van der Harst E, Coene PLO, Wijsman JH, van der Schelling GP, Groot Koerkamp B, Nuyttens JJ, van Eijck CHJ; South West Pancreatic Cancer Care SWPCC consortium. van 't Land FR, et al. Among authors: latifi d. Radiother Oncol. 2023 Jun;183:109541. doi: 10.1016/j.radonc.2023.109541. Epub 2023 Feb 20. Radiother Oncol. 2023. PMID: 36813171 Clinical Trial.
B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients.
Vietsch EE, Latifi D, Verheij M, van der Oost EWA, de Wilde RF, Haen R, van den Boom AL, Koerkamp BG, Doornebosch PG, van Verschuer VMT, Ooms AHAG, Mohammad F, Willemsen M, Aerts JGJV, Krog RT, de Miranda NFCC, van den Bosch TPP, Mueller YM, Katsikis PD, van Eijck CHJ. Vietsch EE, et al. Among authors: latifi d. Front Immunol. 2023 Nov 10;14:1230306. doi: 10.3389/fimmu.2023.1230306. eCollection 2023. Front Immunol. 2023. PMID: 38022530 Free PMC article.
Rintatolimod (Ampligen®) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program.
El Haddaoui H, Brood R, Latifi D, Oostvogels AA, Klaver Y, Moskie M, Mustafa DA, Debets R, van Eijck CHJ. El Haddaoui H, et al. Among authors: latifi d. Cancers (Basel). 2022 Mar 8;14(6):1377. doi: 10.3390/cancers14061377. Cancers (Basel). 2022. PMID: 35326528 Free PMC article.
Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-matched Analysis.
Brada LJH, Daamen LA, Magermans LG, Walma MS, Latifi D, van Dam RM, de Hingh IH, Liem MSL, de Meijer VE, Patijn GA, Festen S, Stommel MWJ, Bosscha K, Polée MB, Nio YC, Wessels FJ, de Vries JJJ, van Lienden KP, Bruijnen RC, Busch OR, Koerkamp BG, van Eijck C, Molenaar QI, Wilmink HJW, van Santvoort HC, Besselink MG; Dutch Pancreatic Cancer Group. Brada LJH, et al. Among authors: latifi d. Ann Surg. 2021 Nov 1;274(5):729-735. doi: 10.1097/SLA.0000000000005120. Ann Surg. 2021. PMID: 34334641